These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 24317448)

  • 1. BCR-ABL disrupts PTEN nuclear-cytoplasmic shuttling through phosphorylation-dependent activation of HAUSP.
    Morotti A; Panuzzo C; Crivellaro S; Pergolizzi B; Familiari U; Berger AH; Saglio G; Pandolfi PP
    Leukemia; 2014 Jun; 28(6):1326-33. PubMed ID: 24317448
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HAUSP compartmentalization in chronic myeloid leukemia.
    Morotti A; Panuzzo C; Crivellaro S; Carrà G; Guerrasio A; Saglio G
    Eur J Haematol; 2015 Apr; 94(4):318-21. PubMed ID: 25082234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The deubiquitinylation and localization of PTEN are regulated by a HAUSP-PML network.
    Song MS; Salmena L; Carracedo A; Egia A; Lo-Coco F; Teruya-Feldstein J; Pandolfi PP
    Nature; 2008 Oct; 455(7214):813-7. PubMed ID: 18716620
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unleashing the Guardian: The Targetable BCR-ABL/HAUSP/PML/PTEN Network in Chronic Myeloid Leukemia.
    Morotti A; Torti D; Carra G; Panuzzo C; Crivellaro S; Taulli R; Fava C; Guerrasio A; Saglio G
    Curr Drug Targets; 2017; 18(4):389-395. PubMed ID: 27291926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BCR-ABL promotes PTEN downregulation in chronic myeloid leukemia.
    Panuzzo C; Crivellaro S; Carrà G; Guerrasio A; Saglio G; Morotti A
    PLoS One; 2014; 9(10):e110682. PubMed ID: 25343485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PTEN is a tumor suppressor in CML stem cells and BCR-ABL-induced leukemias in mice.
    Peng C; Chen Y; Yang Z; Zhang H; Osterby L; Rosmarin AG; Li S
    Blood; 2010 Jan; 115(3):626-35. PubMed ID: 19965668
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pml and TAp73 interacting at nuclear body mediate imatinib-induced p53-independent apoptosis of chronic myeloid leukemia cells.
    Liu JH; Liu CC; Yen CC; Gau JP; Wang WS; Tzeng CH
    Int J Cancer; 2009 Jul; 125(1):71-7. PubMed ID: 19291793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of BCR-ABL-Y177-mediated p27kip1 phosphorylation and cytoplasmic localization in enhanced proliferation of chronic myeloid leukemia progenitors.
    Chu S; McDonald T; Bhatia R
    Leukemia; 2010 Apr; 24(4):779-87. PubMed ID: 20200561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BCR-ABL inactivates cytosolic PTEN through Casein Kinase II mediated tail phosphorylation.
    Morotti A; Panuzzo C; Crivellaro S; Carrà G; Fava C; Guerrasio A; Pandolfi PP; Saglio G
    Cell Cycle; 2015; 14(7):973-9. PubMed ID: 25608112
    [TBL] [Abstract][Full Text] [Related]  

  • 10. hnRNP A1 nucleocytoplasmic shuttling activity is required for normal myelopoiesis and BCR/ABL leukemogenesis.
    Iervolino A; Santilli G; Trotta R; Guerzoni C; Cesi V; Bergamaschi A; Gambacorti-Passerini C; Calabretta B; Perrotti D
    Mol Cell Biol; 2002 Apr; 22(7):2255-66. PubMed ID: 11884611
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of apoptosis by directing oncogenic Bcr-Abl into the nucleus.
    Huang ZL; Gao M; Li QY; Tao K; Xiao Q; Cao WX; Feng WL
    Oncotarget; 2013 Dec; 4(12):2249-60. PubMed ID: 24158537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Src family kinases mediate cytoplasmic retention of activated STAT5 in BCR-ABL-positive cells.
    Chatain N; Ziegler P; Fahrenkamp D; Jost E; Moriggl R; Schmitz-Van de Leur H; Müller-Newen G
    Oncogene; 2013 Aug; 32(31):3587-97. PubMed ID: 22926520
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AHI-1 interacts with BCR-ABL and modulates BCR-ABL transforming activity and imatinib response of CML stem/progenitor cells.
    Zhou LL; Zhao Y; Ringrose A; DeGeer D; Kennah E; Lin AE; Sheng G; Li XJ; Turhan A; Jiang X
    J Exp Med; 2008 Oct; 205(11):2657-71. PubMed ID: 18936234
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting of GSK3β promotes imatinib-mediated apoptosis in quiescent CD34+ chronic myeloid leukemia progenitors, preserving normal stem cells.
    Reddiconto G; Toto C; Palamà I; De Leo S; de Luca E; De Matteis S; Dini L; Passerini CG; Di Renzo N; Maffia M; Coluccia AM
    Blood; 2012 Mar; 119(10):2335-45. PubMed ID: 22262776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LASP1 is a novel BCR-ABL substrate and a phosphorylation-dependent binding partner of CRKL in chronic myeloid leukemia.
    Frietsch JJ; Kastner C; Grunewald TG; Schweigel H; Nollau P; Ziermann J; Clement JH; La Rosée P; Hochhaus A; Butt E
    Oncotarget; 2014 Jul; 5(14):5257-71. PubMed ID: 24913448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intracellular protein trafficking kinetics in chronic myeloid leukemia stem cells using a microfluidic platform.
    Faley S; Copland M; Reboud J; Cooper JM
    Integr Biol (Camb); 2012 Apr; 4(4):368-73. PubMed ID: 22344285
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blockade of Y177 and Nuclear Translocation of Bcr-Abl Inhibits Proliferation and Promotes Apoptosis in Chronic Myeloid Leukemia Cells.
    Li Q; Huang Z; Gao M; Cao W; Xiao Q; Luo H; Feng W
    Int J Mol Sci; 2017 Mar; 18(3):. PubMed ID: 28257089
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nucleophosmin/B26 regulates PTEN through interaction with HAUSP in acute myeloid leukemia.
    Noguera NI; Song MS; Divona M; Catalano G; Calvo KL; García F; Ottone T; Florenzano F; Faraoni I; Battistini L; Colombo E; Amadori S; Pandolfi PP; Lo-Coco F
    Leukemia; 2013 Apr; 27(5):1037-43. PubMed ID: 23183427
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subcellular distribution of p210(BCR-ABL) in CML cell lines and primary CD34+ CML cells.
    Patel H; Marley SB; Greener L; Gordon MY
    Leukemia; 2008 Mar; 22(3):559-71. PubMed ID: 18059481
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Depletion of Pleckstrin homology domain leucine-rich repeat protein phosphatases 1 and 2 by Bcr-Abl promotes chronic myelogenous leukemia cell proliferation through continuous phosphorylation of Akt isoforms.
    Hirano I; Nakamura S; Yokota D; Ono T; Shigeno K; Fujisawa S; Shinjo K; Ohnishi K
    J Biol Chem; 2009 Aug; 284(33):22155-22165. PubMed ID: 19261608
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.